Axsome Therapeutics, Inc. (AXSM)

Axsome Therapeutics Statistics

Total Valuation

AXSM has a market cap or net worth of $4.26 billion. The enterprise value is $4.31 billion.

Market Cap	4.26B
Enterprise Value	4.31B

Important Dates

The next confirmed earnings date is Tuesday, November 12, 2024, before market open.

Earnings Date	Nov 12, 2024
Ex-Dividend Date	n/a

Share Statistics

AXSM has 48.00 million shares outstanding. The number of shares has increased by 9.90% in one year.

Shares Outstanding	48.00M
Shares Change (YoY)	+9.90%
Shares Change (QoQ)	+0.38%
Owned by Insiders (%)	0.52%
Owned by Institutions (%)	76.21%
Float	35.77M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	15.00
Forward PS	9.12
PB Ratio	42.91
P/FCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	n/a
EV / Sales	14.78
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.48, with a Debt / Equity ratio of 1.86.

Current Ratio	2.48
Quick Ratio	2.34
Debt / Equity	1.86
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-68.21

Financial Efficiency

Return on equity (ROE) is -161.69% and return on invested capital (ROIC) is -43.19%.

Return on Equity (ROE)	-161.69%
Return on Assets (ROA)	-28.23%
Return on Capital (ROIC)	-43.19%
Revenue Per Employee	$534,842
Profits Per Employee	-$566,150
Employee Count	545
Asset Turnover	0.50
Inventory Turnover	2.31

Taxes

Income Tax	-1.00M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +43.93% in the last 52 weeks. The beta is 1.25, so AXSM's price volatility has been higher than the market average.

Beta (5Y)	1.25
52-Week Price Change	+43.93%
50-Day Moving Average	89.96
200-Day Moving Average	82.36
Relative Strength Index (RSI)	49.09
Average Volume (20 Days)	421,739

Short Selling Information

The latest short interest is 7.76 million, so 16.16% of the outstanding shares have been sold short.

Short Interest	7.76M
Short Previous Month	7.67M
Short % of Shares Out	16.16%
Short % of Float	21.69%
Short Ratio (days to cover)	17.33

Income Statement

In the last 12 months, AXSM had revenue of $291.49 million and -$308.55 million in losses. Loss per share was -$6.52.

Revenue	291.49M
Gross Profit	263.23M
Operating Income	-261.94M
Pretax Income	-309.56M
Net Income	-308.55M
EBITDA	-261.38M
EBIT	-261.94M
Loss Per Share	-$6.52

Balance Sheet

The company has $315.66 million in cash and $191.80 million in debt, giving a net cash position of $123.86 million or $2.58 per share.

Cash & Cash Equivalents	315.66M
Total Debt	191.80M
Net Cash	123.86M
Net Cash Per Share	$2.58
Equity (Book Value)	102.85M
Book Value Per Share	2.15
Working Capital	276.46M

Cash Flow

In the last 12 months, operating cash flow was -$167.49 million and capital expenditures -$528,000, giving a free cash flow of -$168.02 million.

Operating Cash Flow	-167.49M
Capital Expenditures	-528,000
Free Cash Flow	-168.02M
FCF Per Share	-$3.50

Margins

Gross margin is 90.30%, with operating and profit margins of -89.86% and -105.85%.

Gross Margin	90.30%
Operating Margin	-89.86%
Pretax Margin	-106.20%
Profit Margin	-105.85%
EBITDA Margin	-89.67%
EBIT Margin	-89.86%
FCF Margin	-57.64%

Dividends & Yields

AXSM does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-9.90%
Shareholder Yield	-9.90%
Earnings Yield	-6.96%
FCF Yield	-3.79%

Analyst Forecast

The average price target for AXSM is $124.64, which is 40.31% higher than the current price. The consensus rating is "Strong Buy".

Price Target	$124.64
Price Target Difference	40.31%
Analyst Consensus	Strong Buy
Analyst Count	14
Revenue Growth Forecast (5Y)	50.09%
EPS Growth Forecast (5Y)	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

AXSM has an Altman Z-Score of 1.78 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	1.78
Piotroski F-Score	2